ArticleComputational and structural biotechnology journal2026
Next-Generation Sequencing Dataset Downloader and In Silico Sequence Mining: Graphical-User-Interface-Based Tools for Accessible, Multiprobe Target Mining in Next-Generation Sequencing Data.
Article in Computational and structural biotechnology journal, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Next-generation sequencing (NGS) is expanding in clinical practice, yet many pipelines defer actionable decisions until full alignment and taxonomic calling are complete. The primary contribution of In Silico Sequence Mining (ISSM) lies in providing an accessible graphical-user-interface-based workflow for rapid probe-based pre-alignment screening of raw FASTQ/FASTA datasets. ISSM performs probe-based matching of predefined targets directly on raw FASTQ/FASTA files and supports configurable match thresholds and subsampling. We assessed ISSM using 4 datasets, including 34,899 coronavirus genomes, NGS data from CRFK cells infected with feline coronavirus (FCoV), plasma-derived HIV datasets from patients with sepsis, and colorectal cancer sequencing datasets. Public primer/probe panels applied to coronavirus genomes reliably identified targets at a 100% match threshold, while a 95% threshold increased sensitivity with limited false positives. In FCoV samples, strong positives were observed with both FCoV-specific and pan-coronavirus probes, and spurious matches were negligible relative to true-positive read counts. In HIV data, specificity was preserved in controls; under the most permissive screening criterion, HIV probe matches were detected in 170/263 datasets. Subtyping using subtype-specific probes was feasible in 80 datasets, with subtype D most frequent. In colorectal cancer datasets, ISSM supported preliminary KRAS-mutation-associated probe screening. Operationally, ISSM supports rapid post-sequencing triage, prioritization of confirmatory alignments, and rational reflex testing to quantitative polymerase chain reaction/targeted sequencing, improving allocation of bioinformatics resources. Together with the NGS Dataset Downloader, the ISSM provides a user-friendly graphical-user-interface-based program for researchers and clinical users with limited bioinformatics expertise. Software and a reproducible workflow are available at https://github.com/khk1329/NDD-and-ISSM.git.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.